PRIMO Post-Market Clinical Follow Up Study (PRIMO)
Post-Market, Non-Randomized, Multicentre PMCF Study to Monitor the Safety and Performance of Symani System in Microsurgical Reconstructive Procedures in a Real Life Setting
Sponsor: MMI (Medical Microinstruments, Inc.)
Listed as NCT04843436, this NA trial focuses on Blood Vessels, Lymphatic Ducts and Nerves and Free Flaps and remains completed. Sponsored by MMI (Medical Microinstruments, Inc.), it has been updated 21 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
21 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
-
Dec 2025 — Feb 2026 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting NA
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 16 earlier versions
-
Jul 2025 — Aug 2025 [monthly]
Recruiting NA
-
Jan 2025 — Jul 2025 [monthly]
Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2023 — Oct 2023 [monthly]
Recruiting NA
-
Jun 2023 — Sep 2023 [monthly]
Recruiting NA
-
Mar 2023 — Jun 2023 [monthly]
Recruiting NA
-
Dec 2022 — Mar 2023 [monthly]
Recruiting NA
-
Nov 2022 — Dec 2022 [monthly]
Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
-
Apr 2022 — Jun 2022 [monthly]
Recruiting NA
-
Feb 2022 — Apr 2022 [monthly]
Recruiting NA
-
Sep 2021 — Feb 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MMI (Medical Microinstruments, Inc.)
For direct contact, visit the study record on ClinicalTrials.gov .